Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination

Journal of Virology

Volumn 72, Issue 7, 1998, Pages 5472-5480

  Wang, Xu Shan ^a,b   Khuntirat, Benjawan ^a,b   Qing, Keyun ^a,b   Ponnazhagan, Selvarangan ^a,b   Kube, Dagmar M ^a,b   Zhou, Shangzhen ^c   Dwarki, Varavani J ^c   Srivastava, Arun ^a,b,d  

^a INDIANA UNIVERSITY   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS 2; ARTICLE; CELL LINE; GENE THERAPY; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOUTHERN BLOTTING; VIRUS REPLICATION;

EID: 0031746558     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.7.5472-5480.1998     Document Type: Article

References (52)

1. Allen, J. M., D. J. Debelak, T. C. Reynolds, and A. D. Miller. 1997. Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by non-homologous recombination during AAV vector production. J. Virol. 71:6816-6822.
2. Ashktorab, H., and A. Srivastava. 1989. Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J. Virol. 63:3034-3039.
3. Berns, K. I., and R. A. Bohenzky. 1987. Adeno-associated viruses: an update. Adv. Virus Res. 32:243-306.
4. Berns, K. I., and C. Giraud. 1996. Biology of adeno-associated virus. Curr. Top. Microbiol. Immunol. 218:1-23.
5. Berns, K. I., R. M. Kotin, and M. A. Labow. 1988. Regulation of adeno-associated virus DNA replication. Biochim. Biophys. Acta 951:425-429.
6. Chejanovsky, N., and B. J. Carter. 1989. Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication. Virology 173:120-128.
7. Chiorini, J. A., S. M. Wiener, L. Yang, R. H. Smith, B. Safer, N. P. Kilcoin, Y. Liu, E. Urcelay, and R. M. Kotin. 1996. The roles of AAV Rep proteins in gene expression and targeted integration. Curr. Top. Microbiol. Immunol. 218:25-33.
8. Flotte, T. R., S. A. Afione, and P. L. Zeitlin. 1994. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11:517-521.
9. Flotte, T. R., and B. J. Carter. 1995. Adeno-associated virus vectors for gene therapy. Gene Ther. 2:357-362.
10. Giraud, C., E. Winocour, and K. I. Berns. 1995. Recombinant junctions formed by site-specific integration of adeno-associated virus genome into an episome. J. Virol. 69:6917-6924.
11. Hargrove, P. W., E. F. Vanin, G. J. Kurtzman, and A. W. Nienhuis. 1997. High-level globin expression mediated by a recombinant adeno-associated virus genome that contains the 3′ γ-globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 89:2167-2175.
12. Hauswirth, W. W., and K. I. Berns. 1977. Origin and termination of adenoassociated virus DNA replication. Virology 78:488-499.
13. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
14. Im, D.-S., and N. Muzyczka. 1989. Factors that bind to adeno-associated virus terminal repeats. J. Virol. 63:3095-3104.
15. Im, D.-S., and N. Muzyczka. 1990. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61:447-457.
16. Im, D.-S., and N. Muzyczka. 1992. Partial purification of adeno-associated virus Rep78, Rep68, Rep52, and Rep40 proteins and their biochemical characterization. J. Virol. 66:1119-1128.
17. Koeberl, D. D., I. E. Alexander, C. L. Halbert, D. W. Russell, and A. D. Miller. 1997. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 94:1426-1431.
18. Kotin, R. M., and K. I. Berns. 1989. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170:460-467.
19. Kotin, R. M., J. C. Menninger, D. C. Ward, and K. I. Berns. 1991. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831-834.
20. Kotin, R. M., M. Siniscalco, R. J. Samulski, X. Zhu, L. Hunter, C. A. Laughlin, S. McLaughlin, N. Muzyczka, M. Rocchi, and K. I. Berns. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87:2211-2215.
21. Kube, D. M., S. Ponnazhagan, and A. Srivastava. 1997. Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells. J. Virol. 71:7361-7371.
22. Kube, D. M., and A. Srivastava. 1997. Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions. Nucleic Acids Res. 25:3375-3376.
23. Lusby, E., K. H. Fife, and K. I. Berns. 1980. Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J. Virol. 34: 402-409.
24. McCarty, D. M., D. J. Pereira, I. Zolotukhin, X. Zhou, J. H. Ryan, and N. Muzyczka. 1994. Identification of linear DNA sequences that specifically bind the adeno-associated virus rep protein. J. Virol. 68:4988-4997.
25. McCarty, D. M., J. H. Ryan, S. Zolotukhin, X. Zhou, and N. Muzyczka. 1994. Interaction of the adeno-associated virus rep protein with a sequence within the palindrome of the viral terminal repeat. J. Virol. 68:4998-5006.
26. Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-129.
27. Nahreini, P., and A. Srivastava. 1989. Rescue and replication of the adenoassociated virus 2 genome in mortal and immortal human cells. Intervirology 30:74-85.
28. Nahreini, P., and A. Srivastava. 1992. Rescue of the adeno-associated virus 2 genome correlates with alterations in DNA-modifying enzymes in human cells. Intervirology 33:109-115.
29. Nahreini, P., M. J. Woody,S. Z. Zhou, and A. Srivastava. 1993. Versatile adeno-associated virus 2-based vectors for constructing recombinant virions. Gene 124:257-262.
30. Podsakoff, G., K. K. Wong, Jr., and S. Chatterjee. 1994. Stable and efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68:5656-5666.
31. Ponnazhagan, S., P. Mukherjee, M. C. Yoder, X.-S. Wang, S. Z. Zhou, J. Kaplan, S. Wadsworth, and A. Srivastava. 1997. Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of trans-duced sequences in mice. Gene 190:203-210.
32. Ponnazhagan, S., X.-S. Wang, M. J. Woody, F. Luo, L. Y. Kang, M. L. Nallari, N. C. Munshi, S. Z. Zhou, and A. Srivastava. 1996. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryotic leukemia cells are non-permissive for AAV infection. J. Gen. Virol. 77:1111-1122.
33. Ponnazhagan, S., M. C. Yoder, and A. Srivastava. 1997. Adeno-associated virus type 2-mediated transduction of murine hemapoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J. Virol. 71:3098-3104.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 1.53-1.110. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Samulski, R. J., K. I. Berns, M. Tan, and N. Muzyczka. 1982. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA 79:2077-2081.
36. Samulski, R. J., L.-S. Chang, and T. Shenk. 1987. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:3096-3101.
37. Samulski, R. J., L.-S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
38. Samulski, R. J., L.-S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
39. Samulski, R. J., A. Srivastava, K. I. Berns, and N. Muzyczka. 1983. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell 33:135-143.
40. Samulski, R. J., X. Zhu, X. Xiao, J. Brook, D. E. Houseman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950.
41. - mutant and correction of terminal palindrome deletions. J. Mol. Biol. 179:1-20.
42. Shaughnessy, E., D. Lu, S. Chatterjee, and K. K. Wong, Jr. 1996. Parvoviral vectors for the gene therapy of cancer. Semin. Oncol. 23:159-171.
43. Snyder, R. O., C. H. Miao, G. A. Patijn, K. Spratt, O. Danos, D. Nagy, A. M. Gown, B. Winther, L. Meuse, L. K. Cohen, A. R. Thompson and M. A. Kay. 1997. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16: 270-276.
44. Srivastava, A. 1987. Replication of the adeno-associated virus DNA termini in vitro. Intervirology 27:138-147.
45. Srivastava, A. 1998. Delivery system for gene therapy: adeno-associated virus 2, p. 257-288. In P. J. Quesenberry, G. S. Stein, B. Forget, and S. Weissman (ed.), Stem cell biology and gene therapy. Wiley-Liss, Inc., New York, N.Y.
46. Srivastava, A., E. W. Lusby, and K. I. Berns. 1983. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol. 45.555-564.
47. Vincent, K. A., S. T. Piraino, and S. C. Wadsworth. 1997. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol. 71:1897-1905.
48. Wang, X.-S., S. Ponnazhagan, and A. Srivastava. 1995. Rescue and replition signals of the adeno-associated virus 2 genome. J. Mol. Biol. 250: 573-580.
49. Wang, X.-S., S. Ponnazhagan, and A. Srivastava. 1996. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions. J. Virol. 70:1668-1677.
50. Wang, X.-S., K. Y. Qing, S. Ponnazhagan, and A. Srivastava. 1997. Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. J. Virol. 71:3077-3082.
51. Wang, X.-S., and A. Srivastava. 1997. A novel terminal resolution-like site in the adeno-associated virus type 2 genome. J. Virol. 71:1140-1146.
52. Wang, X.-S., and A. Srivastava. 1998. Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter. J. Virol. 72:4811-4818.